儿童食物过敏口服免疫疗法的研究进展
Progress in Oral Immunotherapy of Food Allergy in Children
摘要: 在全球范围内，儿童食物过敏(FA)的患病率高达8%，成为影响儿童健康的主要因素之一，并引起了广泛的关注。目前对FA的标准治疗方法是严格回避过敏食物，但存在患者依从性不佳、过敏反应发生、负面心理问题等诸多问题。而近年来，对FA的过敏原免疫疗法的研究是一个非常热门的研究领域，且被认为是FA最有希望的治疗方法。而口服免疫疗法(OIT)是研究最多的方法，但是它仍存在很多问题需要解决。本文就OIT后的疗效、安全性及对生活质量的影响方面的研究进展进行综述。
Abstract: The prevalence of food allergy (FA) in children is as high as 8% worldwide, which has become one of the major factors affecting children’s health and has attracted widespread attention. At present, the standard treatment for FA is to strictly avoid allergic foods, but there are many problems such as poor patient dependence, occurrence of allergic reactions and negative psychological problems. In recent years, allergen immunotherapy (AIT) for FA is a very hot research area, and is considered to be the most promising treatment for FA. Oral immunotherapy (OIT) is the most studied method, but it still has many problems to solve. This article reviews the research progress of efficacy, safety and quality of life after OIT.
文章引用：白金梅, 卢蓉, 高春燕. 儿童食物过敏口服免疫疗法的研究进展[J]. 临床医学进展, 2022, 12(10): 8871-8876. https://doi.org/10.12677/ACM.2022.12101280

参考文献

[1] 赵京. 中国儿童食物过敏现况[J]. 中华临床免疫和变态反应杂志, 2019, 13(4): 271-275.
[2] Pajno, G.B., Fer-nandez-Rivas, M., Arasi, S., et al. (2018) EAACI Guidelines on Allergen Immunotherapy: IgE-Mediated Food Allergy. Allergy, 73, 799-815. [Google Scholar] [CrossRef] [PubMed]
[3] US Food and Drug Administration (2020) FDA Ap-proves First Drug for Treatment of Peanut Allergy for Children.
[4] Loh, W. and Tang, M. (2018) Adjuvant Therapies in Food Immunotherapy. Immunology and Allergy Clinics, 38, 89-101. [Google Scholar] [CrossRef] [PubMed]
[5] Loh, W.Y. and Tang, M.L.K. (2018) Debates in Allergy Medicine: Oral Immunotherapy Shortens the Duration of Milk and Egg Allergy—The Con Argument. World Allergy Organization Journal, 11, Article No. 12. [Google Scholar] [CrossRef] [PubMed]
[6] de Silva, D., Rodríguez del Río, P., de Jong, N.W., et al. (2022) Allergen Immunotherapy and/or Biologicals for IgE- Mediated Food Allergy: A Systematic Review and Meta-Analysis. Allergy, 77, 1852-1862. [Google Scholar] [CrossRef] [PubMed]
[7] Barshow, S.M., Kulis, M.D., Burks, A.W., et al. (2021) Mechanisms of Oral Immunotherapy. Clinical & Experimental Allergy, 51, 527-535. [Google Scholar] [CrossRef] [PubMed]
[8] Wood, R.A., Sicherer, S.H., Vickery, B.P., et al. (2013) The Natural History of Milk Allergy in an Observational Cohort. Jour-nal of Allergy and Clinical Immunology, 131, 805-812.e4. [Google Scholar] [CrossRef] [PubMed]
[9] Jiménez-Saiz, R. and Patil, S.U. (2018) The Multifaceted B Cell Response in Allergen Immunotherapy. Current Allergy and Asthma Reports, 18, 1-8. [Google Scholar] [CrossRef] [PubMed]
[10] Schoos, A.M.M., Bullens, D., Chawes, B.L., et al. (2020) Im-munological Outcomes of Allergen-Specific Immunotherapy in Food Allergy. Frontiers in Immunology, 11, Article ID: 568598. [Google Scholar] [CrossRef] [PubMed]
[11] Jiménez-Saiz, R., Chu, D.K., Waserman, S., et al. (2017) Initiation, Persistence and Exacerbation of Food Allergy. In: Allergy Prevention and Exacerbation, Springer, Cham, 121-144. [Google Scholar] [CrossRef] 
[12] Syed, A., Garcia, M.A., Lyu, S.C., et al. (2014) Pea-nut oral Immunotherapy Results in Increased Antigen-Induced Regulatory T-Cell Function and Hypomethylation of Forkhead Box Protein 3 (FOXP3). Journal of Allergy and Clinical Immunology, 133, 500-510.e11. [Google Scholar] [CrossRef] [PubMed]
[13] Wood, R.A. (2016) Food Allergen Immunotherapy: Current Status and Prospects for the Future. Journal of Allergy and Clinical Immunology, 137, 973-982. [Google Scholar] [CrossRef] [PubMed]
[14] Esmaeilzadeh, H., Alyasin, S., Haghighat, M., et al. (2018) The Ef-fect of Baked Milk on Accelerating Unheated Cow’s Milk Tolerance: A Control Randomized Clinical Trial. Pediatric Al-lergy and Immunology, 29, 747-753. [Google Scholar] [CrossRef] [PubMed]
[15] Jiménez-Saiz, R., Belloque, J., Molina, E., et al. (2011) Human Immuno-globulin E (IgE) Binding to Heated and Glycated Ovalbumin and Ovomucoid before and after in Vitro Digestion. Journal of Agricultural and Food Chemistry, 59, 10044-10051. [Google Scholar] [CrossRef] [PubMed]
[16] Nadeau, K.C., Schneider, L.C., Hoyte, L., et al. (2011) Rapid Oral Desensitization in Combination with Omalizumab Therapy in Pa-tients with Cow’s Milk Allergy. Journal of Allergy and Clinical Immunology, 127, 1622-1624. [Google Scholar] [CrossRef] [PubMed]
[17] Wood, R.A., Kim, J.S., Lindblad, R., et al. (2016) A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab Combined with Oral Immunotherapy for the Treatment of Cow’s Milk Allergy. Journal of Allergy and Clinical Immunology, 137, 1103-1110.e11. [Google Scholar] [CrossRef] [PubMed]
[18] Takahashi, M., Soejima, K., Taniuchi, S., et al. (2017) Oral Immu-notherapy Combined with Omalizumab for High- Risk Cow’s Milk Allergy: A Randomized Controlled Trial. Scientific Reports, 7, Article No. 17453. [Google Scholar] [CrossRef] [PubMed]
[19] Yee, C.S.K., Albuhairi, S., Noh, E., et al. (2019) Long-Term Outcome of Peanut Oral Immunotherapy Facilitated Initially by Omalizumab. The Journal of Allergy and Clinical Immu-nology: In Practice, 7, 451-461.e7. [Google Scholar] [CrossRef] [PubMed]
[20] Nagakura, K., Sato, S., Miura, Y., et al. (2021) A Randomized Trial of Oral Immunotherapy for Pediatric Cow’s Milk- Induced Anaphylaxis: Heated vs Unheated Milk. Pediatric Allergy and Immunology, 32, 161-169. [Google Scholar] [CrossRef] [PubMed]
[21] Virkud, Y.V., Burks, A.W., Steele, P.H., et al. (2017) Novel baseline Pre-dictors of Adverse Events during Oral Immunotherapy in Children with Peanut Allergy. Journal of Allergy and Clinical Immunology, 139, 882-888.e5. [Google Scholar] [CrossRef] [PubMed]
[22] Petroni, D. and Spergel, J.M. (2018) Eosinophilic Esophagitis and Symptoms Possibly Related to Eosinophilic Esophagitis in Oral Immunotherapy. Annals of Allergy, Asthma & Immu-nology, 120, 237-240.e4. [Google Scholar] [CrossRef] [PubMed]
[23] Burk, C.M., Dellon, E.S., Steele, P.H., et al. (2017) Eosinophilic Esophagitis during Peanut Oral Immunotherapy with Omalizumab. The Journal of Allergy and Clinical Immunology: In Practice, 5, 498-501. [Google Scholar] [CrossRef] [PubMed]
[24] Wright, B.L., Fernandez-Becker, N.Q., Kambham, N., et al. (2018) Baseline Gastrointestinal Eosinophilia Is Common in Oral Immunotherapy Subjects with IgE-Mediated Peanut Allergy. Frontiers in Immunology, 9, 2624-2624. [Google Scholar] [CrossRef] [PubMed]
[25] Muraki, M., Gleich, G.J. and Kita, H. (2011) Antigen-Specific IgG and IgA, but Not IgE, Activate the Effector Functions of Eosinophils in the Presence of Antigen. International Archives of Allergy and Immunology, 154, 119-127. [Google Scholar] [CrossRef] [PubMed]
[26] Brandström, J., Vetander, M., Sundqvist, A.C., et al. (2019) Individually Dosed Omalizumab Facilitates Peanut Oral Immunotherapy in Peanut Allergic Adolescents. Clinical & Experimental Al-lergy, 49, 1328-1341. [Google Scholar] [CrossRef] [PubMed]
[27] Cao, S., Borro, M., Alonzi, S., et al. (2021) Improvement in Health-Related Quality of Life in Food-Allergic Patients: A Meta-Analysis. The Journal of Allergy and Clinical Immunology: In Practice, 9, 3705-3714. [Google Scholar] [CrossRef] [PubMed]
[28] Chu, D.K., Wood, R.A., French, S., et al. (2019) Oral Immuno-therapy for Peanut Allergy (PACE): A Systematic Review and Meta-Analysis of Efficacy and Safety. The Lancet, 393, 2222-2232. [Google Scholar] [CrossRef] 
[29] Dunn Galvin, A., McMahon, S., Ponsonby, A.L., et al. (2018) The Longitudinal Impact of Probiotic and Peanut Oral Immunotherapy on Health-Related Quality of Life. Allergy, 73, 560-568. [Google Scholar] [CrossRef] [PubMed]

为你推荐